Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andres J M Ferreri

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Idrugs : the Investigational Drugs Journal|April 6, 2006
Hematologic malignancies: from clinical science to clinical practice - 2nd European CongressAndres J M Ferreri
Blood|February 8, 2024
Predicting outcomes in CNS lymphoma with ctDNAJane N Winter, Andres J M Ferreri
Pharmaceutics|July 27, 2022
Targeting the Blood-Brain Tumor Barrier with Tumor Necrosis Factor-αAngelo Corti, Teresa Calimeri, Flavio Curnis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2003
International Collaborative Group against Primary CNS LymphomasAndres J M Ferreri, Tracy Batchelor, Emanuele Zucca, et al.
Clinical Lymphoma & Myeloma|March 2, 2006
Infectious agents in mucosa-associated lymphoid tissue-type lymphomas: pathogenic role and therapeutic perspectivesMassimo Guidoboni, Andres J M Ferreri, Maurilio Ponzoni, et al.
European Journal of Cancer (Oxford, England : 1990)|April 17, 2007
Primary central nervous system lymphoma: biological aspects and controversies in managementEric M Bessell, Khe Hoang-Xuan, Andres J M Ferreri, et al.
Neuro-Oncology|November 13, 2018
Comprehensive approach to diagnosis and treatment of newly diagnosed primary CNS lymphomaChristian Grommes, James L Rubenstein, Lisa M DeAngelis, et al.
Oncology Reports|June 18, 2004
Prognostic significance of cancer-testis gene expression in resected non-small cell lung cancer patientsGiulio Melloni, Andres J M Ferreri, Vincenzo Russo, et al.
Expert Opinion on Pharmacotherapy|October 10, 2007
Therapeutic management of ocular adnexal MALT lymphomaAndres J M Ferreri, Andrea Assanelli, Roberto Crocchiolo, et al.
The Journal of Pathology|August 5, 2003
Immunoreactivity for cyclin D3 is frequently detectable in high-grade primary gastric lymphomas in the absence of the t(6;14)(p21.1;q32.3) chromosomal translocationGiancarlo Pruneri, Sonia Fabris, Roberta Fasani, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Idrugs : the Investigational Drugs Journal|April 6, 2006
Hematologic malignancies: from clinical science to clinical practice - 2nd European CongressAndres J M Ferreri
Blood|February 8, 2024
Predicting outcomes in CNS lymphoma with ctDNAJane N Winter, Andres J M Ferreri
Pharmaceutics|July 27, 2022
Targeting the Blood-Brain Tumor Barrier with Tumor Necrosis Factor-αAngelo Corti, Teresa Calimeri, Flavio Curnis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2003
International Collaborative Group against Primary CNS LymphomasAndres J M Ferreri, Tracy Batchelor, Emanuele Zucca, et al.
Clinical Lymphoma & Myeloma|March 2, 2006
Infectious agents in mucosa-associated lymphoid tissue-type lymphomas: pathogenic role and therapeutic perspectivesMassimo Guidoboni, Andres J M Ferreri, Maurilio Ponzoni, et al.
European Journal of Cancer (Oxford, England : 1990)|April 17, 2007
Primary central nervous system lymphoma: biological aspects and controversies in managementEric M Bessell, Khe Hoang-Xuan, Andres J M Ferreri, et al.
Neuro-Oncology|November 13, 2018
Comprehensive approach to diagnosis and treatment of newly diagnosed primary CNS lymphomaChristian Grommes, James L Rubenstein, Lisa M DeAngelis, et al.
Oncology Reports|June 18, 2004
Prognostic significance of cancer-testis gene expression in resected non-small cell lung cancer patientsGiulio Melloni, Andres J M Ferreri, Vincenzo Russo, et al.
Expert Opinion on Pharmacotherapy|October 10, 2007
Therapeutic management of ocular adnexal MALT lymphomaAndres J M Ferreri, Andrea Assanelli, Roberto Crocchiolo, et al.
The Journal of Pathology|August 5, 2003
Immunoreactivity for cyclin D3 is frequently detectable in high-grade primary gastric lymphomas in the absence of the t(6;14)(p21.1;q32.3) chromosomal translocationGiancarlo Pruneri, Sonia Fabris, Roberta Fasani, et al.
Pageof 2